Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform

Published:2019-08 Issue: Volume:307 Page:292-301
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Tong J.G.,Evans A.C.,Ho M.L.,Guenther C.M.,Brun M.J.,Judd J.,Wu E.,Suh J.^ORCID

Funder

National Institutes of Health

Cancer Prevention and Research Institute of Texas

National Institutes of Health T32 Training Grant Fellowship

National Science Foundation Fellowship

American Heart Association Predoctoral Fellowship

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Recent progress in the diagnosis and treatment of ovarian cancer;Jelovac;CA Cancer J. Clin.,2011

3. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on Gynecologic oncology;Benedet;Int. J. Gynaecol. Obstet.,2000

4. Current genome editing tools in gene therapy: new approaches to treat cancer;Shuvalov;Curr. Gene Ther.,2015

5. Suicide gene therapy for cancer; old dog new tricks;P;J. Genet. Syndr. Gene Ther.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an Enzyme-Linked Immunosorbent Spot Assay for the Assessment of Adeno-Associated Virus Peptides to Examine Immune Safety;Human Gene Therapy;2024-07-01

2. Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/−) mice;Molecular Therapy - Nucleic Acids;2024-06

3. Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy;Molecular Therapy - Nucleic Acids;2023-06

4. Gene Therapy for Regenerative Medicine;Pharmaceutics;2023-03-06

5. AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma;Biomedicines;2022-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3